Fas activity mediates airway inflammation during mouse adenovirus type 1 respiratory infection

CD8 T cells play a key role in clearance of mouse adenovirus type 1 (MAV-1) from the lung and contribute to virus-induced airway inflammation. We tested the hypothesis that interactions between Fas ligand (FasL) and Fas mediate the antiviral and proinflammatory effects of CD8 T cells. FasL and Fas e...

Full description

Saved in:
Bibliographic Details
Published in:Virology (New York, N.Y.) Vol. 521; pp. 129 - 137
Main Authors: Adkins, Laura J., Molloy, Caitlyn T., Weinberg, Jason B.
Format: Journal Article
Language:English
Published: United States Elsevier Inc 01-08-2018
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:CD8 T cells play a key role in clearance of mouse adenovirus type 1 (MAV-1) from the lung and contribute to virus-induced airway inflammation. We tested the hypothesis that interactions between Fas ligand (FasL) and Fas mediate the antiviral and proinflammatory effects of CD8 T cells. FasL and Fas expression were increased in the lungs of C57BL/6 (B6) mice during MAV-1 respiratory infection. Viral replication and weight loss were similar in B6 and Fas-deficient (lpr) mice. Histological evidence of pulmonary inflammation was similar in B6 and lpr mice, but lung mRNA levels and airway proinflammatory cytokine concentrations were lower in MAV-1-infected lpr mice compared to infected B6 mice. Virus-induced apoptosis in lungs was not affected by Fas deficiency. Our results suggest that the proinflammatory effects of CD8 T cells during MAV-1 infection are mediated in part by Fas activation and are distinct from CD8 T cell antiviral functions. •Fas and Fas ligand expression increases in the lungs of MAV-1-infected mice.•Fas deficiency does not impair control of MAV-1 replication in the lungs.•Proinflammatory cytokine production is decreased in airways of Fas-deficient mice.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0042-6822
1096-0341
DOI:10.1016/j.virol.2018.06.002